TISSIUM wins FDA approval for sutureless nerve repair platform
The FDA has granted de novo marketing authorisation to TISSIUM’s COAPTIUM CONNECT, representing the first atraumatic option for repairing peripheral nerve damage. The post TISSIUM wins FDA approval for sutureless nerve repair platform appeared first on Medical Device Network.
The FDA has granted de novo marketing authorisation to TISSIUM’s COAPTIUM CONNECT, representing the first atraumatic option for repairing peripheral nerve damage.
The post TISSIUM wins FDA approval for sutureless nerve repair platform appeared first on Medical Device Network.
